Resource utility
The molecular mechanism by which alterations on DAND5 gene increase the risk of the complex multigenic Congenital Heart Disease is still undetermined. The generated corrected iUC-DAND5_455/10C line is the most ultimate control to establish models in order to understand the role of this gene in patients with DAND5 c.455 G > A variant, in terms of the molecular mechanisms of cardiomyocyte proliferation, drug screening, and regenerative medicine.
Resource details
DAND5 is a secreted molecule that controls the bioavailability of NODAL signaling at the organizer during early embryogenesis (Inacio et al., 2013) . The exact localization and temporal expression of NODAL are what determines the correct establishment of the anatomic asymmetries on the visceral organs, in particular, the anatomical development of the heart (Araujo et al., 2014; Belo et al., 2017) . The c.455G > A variant in the functional domain of DAND5 gene causes a significative decrease in the activity of this NODAL antagonist (Cristo et al.,2017a) . This non-synonymous variant was first identified in a patient clinically diagnosed with a ventricular septal defect with overriding aorta, right ventricular hypertrophy, and pulmonary atresia, a case of extreme tetralogy of Fallot (Cristo et al.,2017a) . To better understand the role of DAND5 in the human cardiac development program, we have generated and characterized the NMSUNLi001-A variant cell line, in which the c.455G > A DAND5 variant is heterozygotic (Cristo et al.,2017b) . This iPSC line was generated using Sendaivirus reprogramming system, retained a stable karyotype, expressed pluripotency markers (e.g., NANOG, OCT4, SOX2), and differentiated towards the three germ layers in vitro (Cristo et al., 2017b) .
Here, using CRISPR/Cas9-mediated genome editing, we were able to generate an isogenic DAND5-corrected iPSC line, i.e., c.455 G homozygous. The strategy for gene correction, in which we made use of CRISPR-induced homology directed repair (HDR) technology using a single-stranded oligonucleotide (ssODN) as a repair template, is illustrated in Fig 1A. DNA Sanger sequencing analysis of NMSUNLi003 confirmed the correction of the heterozygotic c.455G > A DAND5 alteration ( Fig 1B) . The genetic identity of this isogenic cell line to the parental NMSUNLi001-A variant cell line was confirmed by STR analysis, showing that all 16 loci tested matched (Table 1 ). The DAND5corrected iPSC line showed a typical human embryonic stem cell (hESC) colony-like morphology with a high nucleus/cytoplasm ratio ( Fig 1C) , and was karyotypically normal ( Fig 1D) . Pluripotency was assessed by immunofluorescence for OCT4, NANOG, and SSEA4 pluripotency markers ( Fig 1E) , and by the expression of endogenous pluripotency factors OCT4, NANOG, KLF4, SOX2 ( Fig 1F) . In vitro embryoid body (EB)-based differentiation, followed by immunofluorescence analysis of the endodermal marker α-fetoprotein (AFP), the mesodermal marker smooth muscle actin (SMA) and the ectodermal marker βIII-tubulin (TUBB3) revealed that the pluripotent isogenic DAND5-corrected iPSC line differentiates into all three germ layers ( Fig 1G) . The presence of mycoplasma was verified by PCR and the result was negative (Supplementary Fig 1) .
Thus, the generated corrected iUC-DAND5_455/10C cell line represents the unmatched control to understand the contribution of the c.455G > A DAND5 variant to the disease phenotype.
Materials and methods

iPSCs culture
Human iPSCs were cultured in StemFlex Medium (Thermo Fisher Scientific) on hESC-Qualified Geltrex (Thermo Fisher Scientific) coated plates at 37°C in a humidified atmosphere (95% air, 5% CO 2 ). Medium was renewed daily and cells passaged using TrypLE Select (Thermo Fisher Scientific) upon reaching 85% confluence.
CRISPR gene correction
The heterozygous non-synonymous variant in exon 2 of DAND5 gene (c.455G > A) was corrected using CRISPR/Cas9-induced homology directed repair technology. A specific sgRNA was designed using the CRISPR design web tool in crispr.mit.edu, and was cloned into pCAG-SpCas9-GFP-U6-gRNA plasmid (Addgene #79144). A total of 1.0 × 10 6 cells were co-nucleofected with 2 µg of the resulting plasmid, and 1 µL of 100 µM ssODN using Neon transfection system (Thermo Fisher Scientific), according to the manufacturer's instructions. After transfection, the cells were cultured in StemFlex Medium (Thermo Fisher Scientific) supplemented with RevitaCell Supplement at a 1X final concentration (Thermo Fisher Scientific), at 37°C in a humidified atmosphere (95% air, 5% CO 2 ). 48 h post-nucleofection, cells were FACS sorted and plated at single cell density into 96-well plates. Clones were screened for the desired base correction by sequencing of amplicons spanning the target site of DAND5 gene exon 2.
Fluorescent immunocytochemistry
Undifferentiated or differentiated iUC-DAND5_455/10C cells were fixed in 4% paraformaldehyde, incubated with primary antibodies overnight at 4°C, listed in Table 2 , and then incubated with Alexa Fluor 488-conjugated secondary antibodies overnight at 4°C. Nuclei were stained with DAPI at room temperature and cell images were acquired with Zeiss Axio Imager Z2 microscope (Carl Zeiss) or Zeiss LSM710 confocal microscope.
In vitro differentiation potential by embryoid bodies formation assay
Embryoid bodies (EBs) consisting of 2000 cells/20 µL in E8 (Thermo Fisher Scientific) medium plus polyvinyl alcohol (SIGMA) and RevitaCell (Thermo Fisher Scientific) were generated using hanging drop method. Two days after, EBs were suspended in 50% E8 medium and 50% differentiation medium (DMEM with 20% FBS, Pen/Strep, NEAA, 2 mM L-glutamine, and 0,1 mM β-mercaptoethanol) (Thermo Fisher Scientific) and grown 3 more days on non-adherent Petri dishes (LABBOX). At this time, the EBs were transferred onto Geltrex-coated lummox 24-well plates (SARSTEDT) and cultured for another 14 days or longer. Then, cells were fixed with 4% formaldehyde and incubated with the indicated primary antibodies specific for the three embryonic germ layers.
Real-time PCR analysis
Real time PCR was carried out with SensiFAST SYBR Lo-ROX Mix Positive staining for expression of pluripotency markers: OCT4, NANOG, SSEA4 Table 2 on an ABI QuantStudio5 Real-Time PCR machine.
Karyotyping
Chromosome analysis was performed using GTG high resolution banding technique at 400-500 band resolution, 30 metaphases analyzed (Service of GenoMed, Diagnósticos de Medicina Molecular, SA, Lisboa, Portugal).
Mycoplasma contamination detection
The absence of mycoplasma was assessed by PCR using two pairs of Primers listed in Table 2 , and Mycoplasmacheck test (Barcode 84397997) by Eurofins Genomics (http://www.eurofinsgenomics.eu/).
STR analysis
Genomic DNA was extracted (Qiagen) from iUC-DAND_455/10C cells (gDNA #10C) and the parental iUC-DAND_455/10 cells (gDNA #7.39) and the cell line authentication (16 loci) was analyzed by STAB VIDA (http://www.stabvida.com/).
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